Sandoz Cuts Full-Year Sales Growth Outlook; Shares Fall 8%
Sandoz lowered its full-year sales growth guidance after short-term biosimilar-supply constraints weighed on third-quarter results. Shares fell as much as 8% on Wednesday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.